Clinical Trials Sponsored by Pulmonx, Inc.

Total 35730 results

Pulmonx International Sàrl

Terminated

Long Term Follow up Investigation of Endobronchial Valves in Emphysema (LIVE)

Pulmonary Emphysema

Germany
Pulmonx International Sàrl

Completed

Improving Patient Outcomes by Selective Implantation of the Zephyr EBV - Study (IMPACT)

COPD Patients With Homogeneous Emphysema | Endoscopic Lung Volume Reduction With Endobronchial Valve

Germany, Austria, Netherlands
Pulmonx Corporation

Active, not recruiting

Zephyr Valve Registry (ZEVR) (ZEVR)

Emphysema

United States
Pulmonx Corporation

Completed

Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study) (LIBERATE)

Emphysema

United States, Netherlands, United Kingdom, Brazil
Pulmonx Corporation

Active, not recruiting

Zephyr Etude Post-Inscription (French Registry)

Emphysema or COPD

France
Pulmonx Corporation

Completed

Safety and Feasibility Study of the Chartis System With Heterogeneous Emphysema Prior to Endobronchial Lung Volume Reduction (ELVR)

Heterogeneous Emphysema

Germany
Pulmonx Corporation

Recruiting

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema (CONVERT_II)

Emphysema or COPD | Emphysema, Pulmonary

Spain, Germany, Italy, Australia
Pulmonx Corporation

Completed

Post-Market Clinical Evaluation of the Zephyr Valve 5.5-LP EBV

Pulmonary Emphysema

United Kingdom, Switzerland, Germany
Pulmonx Corporation

Completed

A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR)

Emphysema

Netherlands, Germany
Pulmonx Corporation

Recruiting

Zephyr Valve Japan Post-Marketing Surveillance

Emphysema | COPD | Severe Emphysema

Japan
Pulmonx Corporation

Active, not recruiting

Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status (CONVERT) (CONVERT)

Emphysema | COPD | Severe Emphysema

United Kingdom, France, Netherlands, Germany, Australia, Italy, Switzerland
Pulmonx Corporation

Active, not recruiting

Video Assisted Thoracic Surgery (VATS) Fissure Completion Prior to Zephyr® Endobronchial Valve Insertion (COVE)

Pulmonary Emphysema

Australia
Pulmonx Corporation

Completed

To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves (TRANSFORM)

COPD | Heterogeneous Emphysema

Netherlands, Sweden, United Kingdom, Germany, France, Belgium
Pulmonx Corporation

Completed

Clinical Investigation of a Modified Staged Treatment Algorithm Using the AeriSeal System (STAGE)

Emphysema

Netherlands, Germany, Austria
Pulmonx Corporation

Completed

Safety and Feasibility Study of the Chartis System

Bronchoscopy

Germany
Pulmonar

Completed

Testing the Elevation as Sleep Apnea Treatment (TEST)

Sleep Apnea Syndromes | Sleep Apnea, Obstructive | Sleep

Brazil
University Medical Center Groningen
Pulmonx Corporation

Active, not recruiting

Mind The Gap - Crossing Borders Study

Emphysema | COPD | Hyperinflation Lung

Netherlands
Beth Israel Deaconess Medical Center
Pulmonx Corporation

Recruiting

Combined Zephyr Valve System With Inter-lobar Fissure Completion for Lung Volume Reduction in Emphysema (COMPLETE-1)

Emphysema or COPD

United States
PulmOne Advanced Medical Devices, Ltd.

Completed

Measurement and Evaluation of Total Lung Capacity (TLC) in the Field of Pulmonary Functional Testing (PFT)

TLC in Patients With and Without Respiratory System Disease

Israel
Grupo Gallego de Cancer de Pulmon

Unknown

STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE (GGCP 055/12)

Carcinoma, Squamous Cell

Spain
Grupo Gallego de Cancer de Pulmon

Unknown

Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

Spain
Grupo Gallego de Cancer de Pulmon
AstraZeneca; Dynamic Solutions

Unknown

Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients

Metastatic Non-Small-Cell Lung Cancer

Spain
McGill University Health Centre/Research Institute...
Pulmonem Inc.

Recruiting

Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19 (DAP-CORONA)

COVID-19

Canada, United States
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Dr. Negrin University Hospital
Asociación Científica Pulmón y Ventilación Mecánica

Completed

Stratification of the Acute Respiratory Distress Syndrome (STANDARDS)

Acute Respiratory Distress Syndrome (ARDS)

Spain
Dr. Negrin University Hospital
Asociación Científica Pulmón y Ventilación Mecánica

Completed

Incidence of Acute Lung Injury in Children (PED-ALIEN)

Children | Acute Lung Injury

Spain
Instituto Canario de Investigacion Biomedica
Asociación Científica Pulmón y Ventilación Mecánica

Completed

Effects of PEEP and FIO2 in ALI and ARDS (HELP)

Acute Respiratory Distress Syndrome | Acute Lung Injury | Acute Respiratory Failure

Spain
Asociación para la Investigación del Cáncer de...
Pivotal S.L.

Terminated

Evaluation of Gender Differences on the Psychosocial and Economic Impact in Patients With Advanced Non-small Cell Lung Cancer (IMPULSO)

Non-small Cell Lung Cancer

Spain
Dr. Negrin University Hospital
Fundación Mutua Madrileña; Asociación Científica Pulmón y Ventilación Mecánica

Completed

Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome (DEXA-ARDS)

Acute Respiratory Distress Syndrome

Spain
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
Vitality in Aging Research Group, Inc.

Withdrawn

VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements

Aging
In-Home Addiction Treatment Institute, Inc.

Suspended

Effects of In-Home Addiction Treatment for First Responders

Substance Use Disorders

United States
Mylan Technologies Inc.
Mylan Inc.

Active, not recruiting

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Contraception

United States, Canada, Puerto Rico
Dr. Negrin University Hospital
Spanish Research Center for Respiratory Diseases; Asociación Científica Pulmón...

Completed

Stratification of the Acute Respiratory Distress Syndrome - A Second Phase Study (STANDARDS-2)

Acute Respiratory Distress Syndrome

Spain
Fundacion Clinica Valle del Lili
Sociedad Interamericana de Cardiología (SIAC); Consejo Interamericano de Falla...

Recruiting

American Registry of Ambulatory or Acute Decompensated Heart Failure (AMERICCAASS)

Heart Failure

United States, Argentina, Bolivia, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Panama, Paraguay, Peru, Suriname, Uruguay, Venezuela, Jamaica, Nicaragua
Hoffmann-La Roche
Tempest Therapeutics; Adagene Inc; Immune-Onc Therapeutics; NiKang Therapeutics...

Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

Advanced Liver Cancers

Korea, Republic of, Taiwan, United States, Israel, China, France, New Zealand
Santen Inc.
ActualEyes Inc.

Active, not recruiting

A Multicenter Study Assessing the Efficacy and Safety of STN1010904 Ophthalmic Suspension 0.03% and 0.1% Compared With Vehicle in Subjects With Fuchs Endothelial Corneal Dystrophy (FECD) (PHANTOM)

Fuchs Endothelial Corneal Dystrophy

United States, France, India

Clinical Trials Sponsored by Pulmonx, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations